New findings in HCV genotype distribution in selected West European, Russian and Israeli regionsVladimir Kartashev, Orna Mor, Matthias Döring et al.|Journal of Clinical Virology|2016Cited by 73
Agreement between an in‐house replication competent and a reference replication defective recombinant virus assay for measuring phenotypic resistance to <scp>HIV</scp>‐1 protease, reverse transcriptase, and integrase inhibitorsFrancesco Saladini, Maurizio Zazzi|Journal of Clinical Laboratory Analysis|2017Cited by 26
Cohort profile: PRESTIGIO, an Italian prospective registry-based cohort of people with HIV-1 resistant to reverse transcriptase, protease and integrase inhibitorsTommaso Clemente, Antonella Castagna, Maria Mercedes Santoro et al.|BMJ Open|2024Cited by 21
Inflammation burden score in multidrug-resistant HIV-1 infectionTommaso Clemente, Vincenzo Spagnuolo, Roberta Caccia et al.|Journal of Infection|2023Cited by 8
Polypharmacy, anticholinergic burden and drug–drug interaction assessment in people with four-class-resistant HIV: data from the PRESTIGIO registryMaria Mazzitelli, Laura Comi, Domenico Pontillo et al.|Journal of Antimicrobial Chemotherapy|2024Cited by 7